Dr. Rohde currently serves as the Director of the Franciscan Institute for World Health and the co-Director of the Franciscan Institute of Science and Health. He has served on the faculty at Franciscan University of Steubenville since 2009 and currently teaches courses in organic and medicinal chemistry. His chemical research involves two major areas of student interest, 1) synthetic support for Neglected Disease research to improve medical treatments for the poor, and 2) new methods development and contract synthesis in support of pharmaceutical drug discovery. In addition to his lab research, he and his family re-locate each summer to Chicago in support of our students participating in our flag-ship off-site collaborative internship program together with AbbVie. In this capacity, he helps our students to take their Franciscan training and experience out into the professional scientific world.
He received a Ph.D. in Organic Chemistry from Harvard University and a Bachelors of Science degree in Chemistry from the The Ohio State University.
Creative Strategies to Establish & Fund Excellent Undergraduate Research at Small Universities, Chemical Sciences at the Interface of Education at the University of Michigan (CSIEUM) Lecture Series, Department of Chemistry, University of Michigan, Ann Arbor, Michigan, March, 15, 2019. (coordinated by Allison Kelly, FUS alum)
A New Opportunity for Engagement of Undergraduates in Organic Chemistry Labs and Research: Redirecting the Focus and the Waste Stream to Help Advance Global Neglected Disease Efforts, Department of Chemistry, West Virginia University, Morgantown, West Virginia, November 1, 2017. (coordinated by Asst. Prof. Blake Mertz)
Making Labs Matter – A Potential WIN4, 2015 Spring NIH/NCATS Presentation, NIH/NCATS Complex, Rockville, MD, February 23, 2015 (coordinated by Ajit Jadhav, Chief NCGC Branch, NIH/NCATS).
Joint Presentation on the Collaborative FUS – FIWH – Abbott/AbbVie, Summer, Undergraduate, Neglected Disease, Internship Program and New Research Initiatives in the FUS Sciences, Co-presenter Mary Grace Russell (FUS senior for student perspective), Kiwanis Club of Steubenville, spring 2015, YWCA, Steubenville, OH (coordinated by Anita Jackson).
DISCOVERY AND METABOLIC STABILIZATION OF POTENT AND SELECTIVE 2-AMINO-N-(ADAMANT-2-YL) ACETAMIDE 11B – HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS. J. MED. CHEM 149-164
Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(adamant-2-yl) Acetamide 11b – Hydroxysteroid Dehydrogenase Type 1 Inhibitors. J. Med. Chem 149-164
MEDICINAL CHEMISTRY OF A NONPEPTIDYL DPP-IV INHIBITOR SERIES
Medicinal Chemistry of a Nonpeptidyl DPP-IV Inhibitor Series. Rohde, Jeffrey, J. Younger Chemists Committee of the American Chemical Society, Illinois Heartland Local Section, 2005 YYC Speaker, Illinois State University
METABOLIC STABILIZATION OF SUBSTITUTED ADAMANTANE
Metabolic stabilization of substituted adamantane